Table 1.
Patient characteristics at T1
| Time Since Stroke | Lesion Side | Age, 5-Yr Range | Sex | MoCa | FM-UE | ARAT |
|---|---|---|---|---|---|---|
| Subacute patients (days) | ||||||
| 29 | R | 31-35 | M | 23 | 59 | 55.5 |
| 8 | L | 61-65 | F | 22 | 53 | 39 |
| 17 | R | 66-70 | F | 23 | 54.5 | 57 |
| 15 | R | 66-70 | F | 23 | 56 | 45 |
| 12 | R | 66-70 | M | 20 | 59 | 45 |
| 30 | R | 21-25 | F | 27 | 64 | 57 |
| 57 | L | 56-60 | M | 25 | 33.5 | 36 |
| 17 | L | 41-45 | F | 20 | 53 | 34.5 |
| 8 | R | 61-65 | M | 21 | 52.5 | 41 |
| 57 | L | 26-30 | M | 28 | 61.5 | 57 |
| 19 | L | 36-40 | F | 26 | 58 | 54 |
| 47 | R | 51-55 | M | 24 | 57 | 56 |
| 9 | L | 61-65 | M | 19 | 56 | 48.5 |
| 12 | R | 81-85 | F | 22 | 38 | 37.5 |
| 43 | R | 71-75 | F | 27 | 21 | 9 |
| 47 | R | 61-65 | F | 30 | 63.5 | 57 |
| 6 | L | 61-65 | M | 20 | 65 | 57 |
| 55 | R | 51-55 | M | 24 | 44 | 37 |
| 21 | L | 51-55 | F | 22 | 64.5 | 57 |
| 19 | R | 91-95 | M | 27 | 26 | n.d. |
| 70 | R | 66-70 | F | 28 | 59.5 | 56 |
| 47 | R | 71-75 | F | 23 | 45 | 54 |
| 14 | L | 61-65 | F | 25 | 61 | 55.5 |
| 17 | R | 46-50 | M | 30 | 62.5 | 57 |
| 12 | L | 71-75 | F | 25 | 57.5 | 56.5 |
| 58 | L | 46-50 | M | 29 | 15 | 11 |
| 51 | R | 56-60 | M | 27 | 11.5 | 3 |
| Chronic patients (months) | ||||||
| 27 | R | 26-30 | F | 30 | 58 | 44.5 |
| 54 | R | 41-45 | M | 30 | 13 | 3 |
| 42 | R | 66-70 | M | 27 | 60 | 57 |
| 27 | R | 66-70 | M | 25 | 13 | 6 |
| 27 | L | 56-60 | M | 25 | 58 | 54.5 |
| 39 | R | 56-60 | M | 25 | 47.5 | 44 |
| 24 | R | 46-50 | M | 29 | 12 | 3 |
| 76 | R | 61-65 | M | 28 | 10 | 7 |
| 11 | R | 51-55 | F | 23 | 62 | 57 |
| 88 | R | 61-65 | F | 25 | 17 | 3 |
| 24 | R | 56-60 | M | 20 | 29.5 | 5.5 |
| 8 | R | 76-80 | M | 20 | 50 | 43 |
| 59 | R | 46-50 | M | 22 | 24 | 42 |
| 20 | R | 56-60 | M | 20 | 17.5 | 3 |
| 72 | L | 36-40 | M | 27 | 60.5 | 55 |
| 58 | L | 51-55 | F | 21 | 9 | 2 |
| 35 | R | 51-55 | M | 26 | 64.5 | 55.5 |
| 7 | L | 66-70 | M | 28 | 64.5 | 57 |
| 7 | R | 46-50 | M | 29 | 27 | 14 |
| 8 | R | 51-55 | F | 28 | 36 | 14.5 |
| 17 | R | 56-60 | F | 26 | 13.5 | n.d. |
| 9 | R | 41-45 | F | 28 | 33 | 25.5 |
| 7 | L | 36-40 | M | 26 | 61 | 57 |
| 59 | R | 56-60 | F | 23 | 18.5 | 3 |
| 95 | L | 66-70 | F | 27 | 64 | 57 |
| 103 | L | 36-40 | F | 27 | 48.5 | 52.5 |
Showing time since stroke, lesion side, age (nonoverlapping 5-yr range), sex, Fugl-Meyer assessment for the upper extremity (FM-UE, max. 66), Montreal Cognitive Assessment (MoCA, max. 30), and Action Research Arm Test (ARAT, max. 57). F, female; L, left; M, male; n.d., not done; R, right.